The University of Maine

DigitalCommons@UMaine
Honors College
Spring 5-2020

The Functional Role of Glia in Peripheral Metabolic Tissue
Emma Paradie

Follow this and additional works at: https://digitalcommons.library.umaine.edu/honors
Part of the Biology Commons, and the Medicine and Health Sciences Commons
This Honors Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted
for inclusion in Honors College by an authorized administrator of DigitalCommons@UMaine. For more information,
please contact um.library.technical.services@maine.edu.

THE FUNCTIONAL ROLE OF GLIA IN PERIPHERAL METABOLIC TISSUE
by
Emma Paradie

A Thesis Submitted in Partial Fulfillment
of the Requirements for a Degree with Honors
(Biology)

The Honors College
The University of Maine
May 2020

Advisory Committee:
Kristy Townsend, Associate Professor of Neurobiology, Advisor
Lynn Atkins, Instructor of Biology
Magdalena Blaszkiewicz, Postdoctoral Research Associate in the School of
Biology and Ecology
Leonard Kass, Associate Professor of Biological Sciences
Sharon Tisher, Lecturer in the School of Economics and Preceptor in the
Honors College

ABSTRACT

With the ever-growing pandemic of obesity comes a multitude of consequential
morbidities, such as increased risk of heart disease and type II Diabetes Mellitus.
Secondary to diabetes is diabetic neuropathy, the regression or dying back of nerves that
often occurs in the extremities, leading to loss of sensation or pain. Additionally, aging is
a risk factor for obesity, diabetes, and neuropathy. Responsible for the communication
between the extremities and peripheral tissues, such as adipose (fat), and the brain, is the
peripheral nervous system. The peripheral nervous system is the umbrella under which
varying types of nerves are designated, including sympathetic, parasympathetic, and
sensory nerves, which have been shown to innervate adipose tissue. Both the peripheral
nervous system (PNS) and central nervous system (CNS) house glial cells, whose
neuron-supporting functions are vital for maintaining homeostasis. Oligodendrocytes are
the myelin-forming cells of the CNS, while Schwann cells are the myelin-forming cells
of the PNS. Myelin is a fatty substance that ensheaths the axons of neurons, insulating
them and allowing signals to be propagated through the body faster. Whereas crosstalk
between glia and the immune system in the CNS is of increasing popularity in current
research, much less is known about relative roles of glia and local immune cells in the
PNS, particularly in adipose. This thesis delves into further investigating the types of glia
that may be present in and interact with adipose tissue nerves. A better understanding of
this interaction in adipose will be beneficial in uncovering mechanisms of proper energy
balance and metabolic health, as well as potentially mitigating the progression of diabetic

neuropathy, or the death of peripheral nerves. To our knowledge, this thesis investigates
the first ever immunopanning experiments for Schwann cells in adipose tissue.
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INTRODUCTION

Obesity Epidemic
The obesity epidemic is rapidly ever-growing around the world despite the
increased recognition of the problem and its associated health risks. Adults having a body
mass index (BMI) of 25.0 kg/m2 to 29.9 kg/m2 are defined as overweight, while those
with a BMI of 30 kg/m2 or higher are defined as obese[1]. According to the World
Health Organization, worldwide obesity is nearly three times what it was in 1975, with a
reported number of 650 million obese adults[2]. The issue at hand does not solely affect
adults, however, and has had major implications in children as well. Children and
adolescents from the ages of 2 to 18 are defined as overweight if they are in the 85th to
94th percentile of the population for their sex and age, and defined as obese if at or above
the 95th percentile[1]. Since the year 2000, the number of overweight children under the
age of 5 in Africa has increased by roughly 50 percent, while in 2016, half of the world’s
overweight or obese population of children under the age of 5 lived in Asia[2]. Once a
more drastic problem in high-income households, obesity has infiltrated into low- and
middle-income households and countries as well.
Factors worldwide that have contributed in countries of all economic statuses
include, but are not limited to, foods that are higher in sugar, fat, and salt, yet lack
nutrients, inadequate amounts of sleep, chronic stress, eating while on-the-go, the
increase in sedentary jobs as a result of technological advances and therefore decreased
physical activity, and various levels of urbanization (i.e. more efficient transportation in
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highly populated areas)[2,3]. In addition to the growing issue around the globe, the
United States has also been greatly impacted by this epidemic. Prevalence estimates
based on self-reported obesity published by the Centers for Disease Control and
Prevention (CDC) showed that in 2011, all fifty states had an obesity prevalence of less
than 35% and eleven states had a prevalence between 20%-25%. By 2018, however, selfreported obesity rates drastically increased, leaving nine states with an obesity prevalence
of over 35% and only three states with a prevalence between 20%-25%[4]. In New
England, Maine remains the state with the highest rate of obesity, which could be in
correlation to both its aging and low-income populations.

Diabetes Mellitus
The human body composition largely depends on the balance between energy
input versus energy expenditure. Factors that may be characterized as energy intake
include diet, appetite, and digestion and nutrient absorption, while those characterized as
energy expenditure may include basal metabolism, thermogenesis, and exercise/physical
activity. As attributes on the energy intake side of the balance, such as diet, begin to
outweigh energy expenditure, complications such as obesity begin to arise as a result.
Individuals are subject to developing obesity based on varying factors, including sex,
environment, genetics, age, and differences in the types of adipose tissue present[5,6].
Along with obesity comes the increased risk for comorbidities, some of which
include stroke, hypertension, some cancers, and type 2 diabetes[1]. Of these, type 2
diabetes is one of the most common results of obesity. According to the American
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Diabetes Association, “diabetes mellitus is a group of metabolic diseases characterized by
hyperglycemia,” or increased blood sugar[7]. This sugar, or glucose, is a vital aspect in
the body’s metabolic health. When there is a normal glycemic index, the body is healthy
and able to carry out its functions. When there is an increased level of glucose in the
blood for extended periods of time, however, metabolic complications can begin to arise.
Type 2 diabetes has historically been diagnosed mostly in adults, although the
number of children and adolescents being diagnosed with type 2 diabetes over the past
decade has increased drastically. Insulin is a hormone that is produced by the beta cells of
the pancreas and is responsible for the uptake of glucose from circulating blood into the
body’s cells. Therefore, glucose and insulin have an inverse relationship in a healthy
individual, where a high level of glucose means there is currently a low level of insulin,
and a high level of insulin would lead to lower levels of circulating glucose. Type 1
diabetes is the result of an autoimmune response in which the immune system mistakenly
attacks the insulin-producing beta cells and thus the body is unable to make normal
amounts of insulin[8]. This generally leads to such minute amounts of insulin in the body
that individuals affected need to take insulin in order to survive. Type 2 diabetes is
generally the result of prolonged, excessively high blood sugar levels. In this scenario,
the beta cells of the pancreas try to make insulin to overcompensate for the high blood
sugar levels. Eventually, the pancreas is unable to keep up with the amount of glucose
and insulin resistance develops[8]. Nearly 85%-95% of all diabetic patients in highincome countries around the globe are diagnosed as type 2 diabetic patients, with the
potential that the rate is even higher in low-income countries[9].
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Diabetic Peripheral Neuropathy
Peripheral neuropathy is an unfortunately common consequence of patients
diagnosed with diabetes. Peripheral neuropathy refers to physiological damage occurring
in the peripheral nerve that is commonly presented in patients as distal degenerative
polyneuropathy beginning in the extremities[10,11]. Roughly 20% of patients with type 2
diabetes will have diabetic peripheral neuropathy at initial diabetes diagnosis, and about
50% of all diabetic patients will inevitable develop diabetic peripheral neuropathy
(DPN)[11,12]. DPN can have devastating effects on the lives of the patients effected and
have a variety of implications. For instance, the regression of the nerve health can lead to
loss of sensation and/or pain, which can in turn lead to much larger life-altering changes
such as gait disturbance, fall-related injuries, and the development of ulcers on the feet,
frequently a preempting lower limb amputation[11].
There are various categories of DPN, with the most common being distal
symmetric polyneuropathy. This type of DPN constitutes nearly 75% of all diabetic
neuropathies and can be characterized in one of three ways; primarily small-fiber,
primarily large-fiber, or a combination of the two[12]. The remaining approximate 25%
of diabetic neuropathies include categories such as treatment-induced neuropathies,
mononeuropathies, and autonomic neuropathies – the most similar to distal symmetric
polyneuropathy despite being mostly non-sensory[12]. There are currently no treatments
for neuropathy, only medications prescribed in hopes of making patients more
comfortable, weight management, blood glucose control, and physical therapy[11,12].
A lot of aspects contribute to the peripheral nerve not maintaining its proper
function. The cell body is housed just outside of the spinal cord in what is called the
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dorsal root ganglion (DRG) or anterior horn cell, and this is where damage can often
begin. The damage can then progress through the rest of the cell and axonal projection,
including the myelin sheath wrapped around it[11]. In patients with diabetes, the
endoneurial microvessels are damaged and therefore cause structural abnormalities in
diabetic nerves[13]. A decrease in the thickness of the basement membrane of these
endoneurial microvessels has also shown to be correlated to decreased myelinated fiber
density[13]. Excessive glycation is common in diabetic nerves, and advanced glycation
end-products (AGE) deposition in various structures of peripheral nerve tissues,
including the axoplasms of Schwann cells, presents an inverse correlation with
myelinated nerve fiber density. In fact, diabetic mice without the gene for the receptor for
AGE (RAGE), have shown protection against neuropathy[13]. Sustained hyperglycemia
leads to oxidative stress and thus the generation of free radicals, eventually causing
mitochondrial damage and leading to downstream effects of reduced neurotrophin-3 (NT3) and nerve growth factor (NGF)[13]. Large-fiber DPN causes patients to be particularly
susceptible to developing foot ulcerations as a result of the loss of sensation in the foot as
well as gait disturbance. Common symptoms often described by the population of
patients with this type of neuropathy are numbness, tingling, and discomfort[11]. This is
a consequence of the “large-diameter myelinated A-beta somatic fibers” being affected
by (generally longstanding) neuropathy, because these fibers are notorious for their role
in touch sensation and joint position[11]. In comparison, small-fiber DPN affects mainly
“small diameter thinly myelinated A-delta fibers” and “unmyelinated C somatic fibers”
responsible for transmission of cold/mechanical pain information, and thermal,
mechanical, and chemical pain signals respectively[11]. As a result, patients often
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complain of painful sensations such as burning and stinging and present with minimal
ability to sense external painful and thermal stimuli in conjunction with decreased
proprioceptive sensation[11].

Nerve Innervation and Neuropathy in Adipose Tissue
In order to maintain a healthy metabolic balance, the exchange of information
between the brain, particularly the hypothalamus, and peripheral tissues is critical.
Communication to the brain from the periphery is not only signals sent from circulating
nutrients and endocrine factors, but also consists of signals from afferent sensory nerves
and efferent sympathetic nerves relaying information to and from the periphery[14].
There are two major divisions of adipose, or fat; brown adipose tissue (BAT) and
white adipose tissue (WAT). While WAT is notorious for its role as the major site of
energy storage, BAT is predominantly known for its thermogenic and energy expenditure
function[5]. It is known that BAT is in relatively high abundance in newborns, but
prevalent in lower amounts of adult humans. Recent research has revealed, however, that
brown adipogenesis can be induced in white fat through various physiological stimuli,
including cold exposure and sympathetic activation[15]. Additionally, adipose tissue is
responsible for secreting various circulating endocrine factors that contribute to the
activation of lipolysis in WAT or thermogenesis in BAT[19]. An example of this is the
release of norepinephrine by sympathetic nerve terminals as a positive regulator of
lipolysis. For these reasons, it is typical for an excess of WAT to be associated with the
obesity epidemic and fat accumulation, while BAT or the browning of white adipose
tissue could contribute to the protection against obesity. One of the major defining
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characteristics of obesity is an increase in fat cell number, making it important to
understand the processes under which this may occur, or how it may be affecting other
physiological processes[16]. Browning and adipocyte mass homeostasis are largely
dependent on nerve supply to the WAT. The sympathetic nervous system (SNS) is known
for conveying energy expenditure signals from the CNS to peripheral tissues[17].
Surgical denervation of SNS fibers in WAT has been shown to increase the number of
adipose cells and thus increase fat pad mass, although there was no increase in the size of
the fat cells themselves[16,18]. SNS innervation of WAT is known for its role in
modulating fat cell proliferation through the release of norepinephrine (NE) that acts to
inhibit fat cells from proliferating freely[18]. This result differs from that of strictly
sensory denervation that shows an increase in the size of fat cells, but no change in
overall fat pad mass[18]. This notable difference is important for investigating the
different roles of both sensory and sympathetic innervation in white adipose tissue, and
their contribution to maintaining proper energy balance.
Historically, peripheral neuropathy has been noted as a metabolic disease in
tissues such as that of the skin and distal extremities, but it has more recently been shown
to have other implications and occur in various other organs, including adipose. While
there is a continued need for further study in metabolic functions and mechanisms, it has
been shown in a cohort of experiments including aging, obesity, and diabetes, that WAT
from both mice and humans fails to maintain healthy innervation[17]. Failure to maintain
proper innervation can have serious implications in the energy balance roles of the nerve
fibers affected, as we know these nerves are responsible for processes such as lipolysis
(releasing fatty acids through the breakdown of fats) and thermogenesis (the generation
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of heat, particularly in BAT due to UCP-1)[17]. Leptin, a hormone produced by adipose
tissue, is responsible for the breakdown of white adipose tissue via its communication
with the brain. This lipolytic effect is knowingly modulated by sympathetic nerve
fibers[20]. Thus, denervation of sympathetic nerves in adipose tissue can also have
detrimental effects to the tissue’s health.
Such findings further the necessity for looking into possible solutions and
treatments for neuropathy, particularly that of adipose tissue. Using an axonal growth
cone marker (GAP43), a pan-neuronal marker (PGP9.5), and a sympathetic nerve marker
(tyrosine hydroxylase or TH), it has been depicted that cold exposure intervention
enhances nerve plasticity in the peripheral adipose tissue[17]. Cold exposure
interventions in visceral adipose tissue (VAT) have also been shown to induce significant
weight loss in mice fed high-fat diets (HFD), as well as significant increase of metabolic
responses, and the remodeling of the adipose[21]. This remodeling in subcutaneous WAT
involves the increase in sympathetic fiber innervation shown through expression of
tyrosine hydroxylase (TH), a common dopaminergic marker, as well as pan-neuronal
marker TUBB3. Other factors that contributed to the adipose remodeling were
angiogenesis, browning of the adipose tissue, and an induced accumulation of
extracellular matrix around the VAT adipocytes[21].
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Risk of Neuropathy Increases with Age
According to the U.S. Census Bureau, Vintage 2018 Population Estimates, Maine
has the highest population percentage of individuals sixty-five or older in the nation[22].
Aging individuals are at higher risk for the development of type 2 diabetes and therefore
the development of neuropathy. The level of risk and severity for the development of
diabetic neuropathy in an aged population is dependent upon a plethora of factors,
including hyperglycemia, hypertension, and smoking[23]. PGP9.5, a pan-neuronal
marker, exemplifies a significant decrease in inguinal subcutaneous WAT of both mice
and humans is seen as age increases, indicating the severe loss of nerve innervation in
this tissue[17]. Additionally, increased age in mice correlated with a trend for increased
subcutaneous WAT weight and a trend for decreased levels of the SNS marker, TH[17].
Aged populations with diabetic neuropathy are also at a high risk of exhibiting
microvascular complications, as well as decreased innervation surrounding the
vasculature in their subcutaneous WAT depots[17,23]. Loss of proper vascular function
could be a crucial factor, as it signifies loss of well-distributed nutrients to the affected
regions.
The Importance of Glia in Nerve Health
Glia are a crucial component of the neurological system as they are
characteristically known as the neuronal support cells. The word “glia” is derived from
the Greek word for “glue,” which is fitting given the function of these cells[24]. There
are various types of glia throughout the body, with unique types in varying niches. For
instance, glia such as astrocytes, microglia, and oligodendrocytes reside in the CNS,
Schwann cells and satellite glia are characteristic of the PNS, and the enteric nervous
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system has to date identified a handful of residential glia types in the gut. There are a few
characteristics that strongly distinguish glia from their neuronal counterparts. To begin
with, nerve cells interact with one another and communicate via electrical signaling
(often referred to as action potentials) and interactions at the synapse, while glia cells
simply contribute supportive functions in these processes, such as modulating
neurotransmitter release and uptake and the rate at which signals are propagated along the
nerve cell[24].
While properties such as these are known to be functions of glia, there are still so
many more functions that have yet to be discovered. In addition to the variety of these
cells, their locations and interactions with other cell types make it difficult to pinpoint
such functions. The most research and attention has thus far been directed towards glia in
the central nervous system, particularly the brain. In the brain and spinal cord, one of the
most studied glial cell types is astrocytes. These cells have a very distinct morphological
structure, leading them to frequently be characterized as star-shaped. Throughout the
brain, there is an exuberant number of classifications of astrocytes based on morphology
and location, creating much difficulty in determining the various roles and implications
of each[25]. Some of the roles of astrocytes consist of regulating blood-brain barrier
permeability, which is consequential in preventing the entrance of harmful substances
into the brain, including toxins and bacteria that could cause damage to the brain
tissue[25]. It has been shown that astrocytes express the same genes as other cell
progenitors, giving them the ability to be proliferative. This function can have
implications if proliferation gets out of hand, leading to inflammation of the astrocytes
which is generally characterized by an upregulation of glial fibrillary acidic protein
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(GFAP). This inflammation state can sometimes lead to the loss of proper astrocytic
function, leading to cellular senescence and showing correlations to many
neurodegenerative diseases, including Alzheimer’s disease, Huntington’s disease, and
recently exhibiting roles in amyotrophic lateral sclerosis (ALS)[25].
Another glial cell type of high importance in the brain and spinal cord is
microglia. Microglia are notorious for being the “resident macrophages” of the CNS,
meaning they are crucial to phagocytosis in this region of the body[26]. Phagocytosis is a
process required for healthy pruning of the brain and includes recognizing, engulfing, and
digesting foreign, harmful, or unnecessary particles or debris[26]. Not only is this
function important for the regulation of both innate and adaptive immune responses, but
it is continuing to prove necessary for modulating pathological processes[27]. The need
for further research regarding the role of microglia in maintaining a healthy brain versus
contributing to brain damage remains necessary. Techniques such as using mutant
rodents or microglial depletion assays are beginning to open up the possibility of such a
research and have begun showing results indicating that the loss of microglia leads to
cognitive developmental deficits in rodents[27]. There is even speculation of the role of
microglia in modulating adult neurogenesis[27].
The last of the significant glia trio in the CNS is oligodendrocytes.
Oligodendrocytes originate from oligodendrocyte precursor cells and are infamous for
their role in myelination[28]. Oligodendrocytes are able to wrap their branches around
multiple neuronal axons, which can be an extremely metabolically taxing process,
leaving these cells susceptible to cytotoxic or excitotoxic infiltration[28]. Affected
oligodendrocytes can therefore have function alterations that can lead to demyelinating
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diseases like multiple sclerosis or other pathological diseases like schizophrenia and
Alzheimer’s disease[28].
While there are three distinguishable categories of glia in the CNS, there are only
two that are recognized in the PNS – satellite glia cells that reside the ganglia and
Schwann cells in the peripheral nerves. In rodent models, satellite glia have been shown
to control cholinergic transmission in sympathetic neuron-to-neuron interactions[29].
Satellite glia have also been shown to contribute to overall sympathetic neuronal health
and survival, in addition to promoting synapse formation[29]. Despite this knowledge,
there is still much research to be done to further understanding all of the functions of
satellite glia. Schwann cells, who are often discussed in regards of myelinating peripheral
nerves, are present in the body in many different developmental stages, correlating them
to a variety of different roles – many of which still require further research. Lack of
knowledge about the role of Schwann cells in adipose tissue, their role in nurturing
neurons, and their communication processes with other cells – particularly immune cells
– leaves the field with exciting potential for discovery.

Schwann Cell Development
Schwann cells are somewhat of an enigma in the peripheral nervous system.
Although they are notorious for their role in axonal myelination, more and more research
regarding Schwann cells continues to reveal interesting additions to the responsibilities of
these cells. The lack of knowledge regarding the wide array of Schwann cell functions
and communications is invigorating, allowing for the development of innovative avenues
to study hypotheses of their functions. Extrapolating the relatively little amount of
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information we know about glia in the CNS and hypothesizing how similar roles may be
carried out in the PNS by Schwann cells could lead to endless new discoveries about the
importance of this cell group.
During embryonic development, the neural crest gives rise to neural crest stem
cells, which are in turn responsible for giving rise to a multitude of differing sub-lineages,
including that of Schwann cells[30]. Schwann cell lineage includes many different
variations of these specialized cells, as can be seen in Figure 1.
Schwann Cell Precursors (SCP) are the first developmental stage in Schwann cell
lineage when beginning to differentiate from neural crest cells. These cells maintain some
stem-cell-like characteristics after this initial differentiation, allowing them to be
multipotent, a feature shared amongst early glial cells in both the PNS and CNS[30]. As
multipotent cells, SCPs also have the ability to differentiate into cells such as
melanocytes, endoneurial fibroblasts, parasympathetic neurons, chromaffin cells, and
tooth pulp cells[30]. Additionally, experiments have shown that parasympathetic nerves
are also capable of being derived from SCPs, giving SCPs a list of differentiation
possibilities[31,32]. Myelin protein zero (mpz) is a gene that encodes for myelin protein
zero, notorious for its expression in myelinating Schwann cells. Research has shown,
however, that mpz is also expressed at low basal levels in Schwann cell lineage long
before they are differentiated into myelinating Schwann cells, as it has been detected in
SCPs, immature Schwann cells, and even a small population of neural crest cells before
axonal outgrowth from the spinal cord has even begun[30]. SCPs are most often
associated with large nerve branches, in which they embed themselves amongst bundles
of axons as well as among the axons at the nerve surface. After the conversion of neural
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crest cells to SCPs in nerves, there is a gene expression change that occurs in hundreds of
genes – generally an upregulation of functional classes, such as molecules involved in
cell differentiation and transcription factors[30]. These factors are important, because
they are often the genes encoding for many of the proteins used to identify Schwann
cells, such as myelin basic protein (MBP) and desert hedgehog (Dhh), and S100b [30,33].
Next in the Schwann cell lineage are immature Schwann cells. This
developmental stage occurs during embryonic days 15-16 in mice and shows association
between these cells, connective tissue, basal lamina inside nerves[30]. Part of the
Schwann cell membrane is the basil lamina, which surrounds the cell and is responsible
for housing extracellular matrix molecules, such as laminin[34,35]. In conjugation with
the laminin receptor, b1-integrin, and other signaling cascades downstream, various
laminin isoforms work to configure the appropriate alignment of Schwann cells to
axons[36]. Components of the extracellular matrix regulate function, architecture, and
function of myelin during the development of Schwann cells[35]. Laminin and its role
differ throughout Schwann cell lineage, depicting a vital role in stimulation of radial
sorting. Radial sorting is a process through which immature Schwann cells – originally
congregated around groups of axons – continue to proliferate so that there is a 1:1 ratio of
Schwann cells to axons[24,26,27]. Once at this 1:1 ratio, the cells in rodents typically
become “pro-myelin” cells and go on to form myelinating Schwann cells, but in humans,
there are a significant number of axons that remain unmyelinated at the 1:1 ratio,
eventually going on to form Remak bundles, or non-myelin Schwann cells[30].
Schwann cell plasma membranes are constituted of a high lipid content and
cholesterol, playing an important role in the process of myelination[34]. Schwann cells
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ensheath axons in a methodical manner; the nucleus remains fixed, but the inner turn of
the Schwann cell membrane creates the myelin sheath by spiraling around the axon to
continuously build membranous layers, known as lamellae[34]. The amount of
Neuregulin I-type III exposed on the membrane of the axon sends signals to the Schwann
cell whether or not it should myelinate, as well as dictating how much myelin should be
produced by myelinating Schwann cells[33,37]. Proliferation of Schwann cells occurs
before cells have gone through radial sorting, as myelinating Schwann cells generally do
not undergo division. Increased proliferation generally coincides with precursor to
immature Schwann cell conversion and appears to be correlated to an increase of
intracellular cAMP[33]. Myelin is unique in its composition of mostly lipids with some
low-molecular weight proteins, contributing to how densely packed it is[36]. The mere
structure of myelin indicates that there is likely an unusual form of transport within the
cell. One of the difficulties in studying this topic in cell biology, is that the myelin is
packed so tightly that it is difficult to view with light microscopy. Although not the same
as Schwann cells, oligodendrocytes, the myelinating cells of the CNS, have very similar
composition to that of Schwann cells, and have been able to be cultured and studied to an
extent in vivo[36]. Results of culturing oligodendrocytes indicate that vesicle transport is
confined to the cell body of the cell and doesn’t carry through the layers of myelin
sheath. Myelin is known to be composed of the cytoplasmic protein myelin basic protein
(MBP) and proteolipid protein (PLP), the latter of which is an integral protein and may be
an influential factor in membrane trafficking[38].
Mitochondria and other cytosolic components are located in the outermost layer
of myelinating Schwann cells. This is termed the abaxonal region and is separated from
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the region of the cell that is directly attaching to the axon by myelin sheath. Experiments
indicate that ATP is released from nerve axons, signals to the abaxonal membrane of
myelinating Schwann cells, and is therefore able to communicate with the mitochondria
housed there[39]. In fact, extracellular ATP increases with increasing axonal firing and
leads to activation of purinergic receptors. This is important, as purinergic signaling is
shown to enhance Schwann cell mitochondrial Ca2+ release, and this increased
intracellular Ca2+ concentration in the mitochondrial matrix enhances ATP
production[39]. In Schwann cells during catabolic processes, lactate (that has been
converted from glycogen) is taken by monocarboxylate transporters, oxidized to
pyruvate, and then the newly created pyruvate is brought to the axon to join the Krebs
cycle and produce ATP, just as typical eukaryotic cell metabolism[40]. As research
continues in this field, indicating the importance of Schwann cell mitochondria in
myelination and nerve health, there are hypotheses that Schwann cell mitochondrial
dysfunction could contribute to neuropathic peripheral nerves[41].
Unlike the myelinating cells of the CNS, oligodendrocytes, Schwann cells are not
fixed once in these states, allowing them a characteristic deemed as plasticity, through
which these cells are able to convert themselves into regenerative or repair cells in a time
of injury[42]. These repair cells, deemed “Bungner” cells, are converted to such cells
from myelinating Schwann cells via the transcription factor c-Jun and reenter the cell
cycle after injury to help with reparations to injured nerves[43]. The mechanistic
conversion back into myelinating cells still requires further research, as does the assumed
role of non-myelinating Schwann cells to also be converted into repair Schwann cells.
There is continuing research, however, that indicates the role of repair Schwann cells in
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supporting damaged neurons while promoting axonal regrowth and assisting those axons
in finding their targets, recruitment of macrophages, and clearing unnecessary
myelin[44]. Additionally, it is known that Schwann cells are capable of a type of
autophagy deemed “myelinophagy,” but recent research has also focused on the concept
of “demyelinating” Schwann cells and their roles in demyelinating neuropathies[45].
These cells are believed to play an important role in myelin clearance in conditions both
with and without intact axons, seeming to play quite similar roles to the repair Schwann
cell described by Jessen and Mirsky – both with potentially vital roles in peripheral
neuropathies[45].

Figure 1. Schwann cell lineage: from neural crest cell to myelinating and nonmyelinating Schwann cells (Taken from Jessen et. al., 2015; Schwann cells:
development and role in nerve repair).
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Immunopanning
With limited ways of isolating cells and their respective functions, the first
instance of any sort of “panning” was in the year 1980, and the experiment’s goal was to
isolate and culture astrocytes from the brain by negatively selecting unwanted immune
cells[46]. Ben Barres took full advantage of the upcoming technique. He began using it in
1988 to isolate and purify various cell types from retinal ganglion cells, after which point
he continued to use it for an extensive number of experiments and published papers[47].
This was a successful technique for Barres as it was relatively cheap and quick, while
providing reliable results. Immunopanning has been a procedure used predominantly in
the field of neuroscience surrounding the CNS, but has made a few appearances in
experiments for the PNS. One of the earliest documented isolations of Schwann cells
through a similar, simple “panning” method was done by Assouline and colleagues in
1983 with a peripheral nerve taken from a rat model[48].
In the experiments conducted for this thesis, the written protocol was adapted
from one published by Cold Spring Harbor[49]. The protocol from Cold Spring Harbor
was for isolating Schwann cells from the sciatic nerve – the only peripheral tissue (of any
kind) to have used immunopanning. Given that the sciatic nerve and adipose tissue are
quite different in mass, fibrosity, and other constituents, it was necessary for there to be a
learning curve for adaptations to be made to the protocol. The most eminent part of the
protocol needing refining was the division for the digestion of the adipose tissue.
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Fluorescence-activated Cell Sorting (FACS)
One of the most commonly used techniques in separating cell sub-populations
within a given population is through using fluorescent labeling. Tissues are digested with
protocols specific to that given tissue and cells are isolated following a protocol. Once the
cells are isolated, they are labeled with fluorophore-conjugated antibodies that correlate
to the specific proteins of interest. During sorting, each population of cells (for instance,
that of adipose taken from one animal) is placed into a flow cytometer. One at a time, the
cells go to leave the nozzle tip of the machine. As they do so, they enter a single droplet
that is passed through a laser to detects its fluorescent label and is then given an electric
charge based on the labeled fluorescence of the cell. In combination with the given
charges, deflection plates cause cells to either be attracted to or repelled from them and
into their relative collection tubes [50].
FACS is a very successful and well-practiced method for sorting cells based on
their phenotypes, but does require the proper, expensive equipment and someone who is
well versed in using the equipment. Although FACS certainly has its limitations, it is also
more beneficial in comparison to other techniques, such as magnetic-activated cell
sorting (MACS), in that the flow cytometry allows more flexibility and accuracy in
distinguishing the phenotypes of various cells[51].
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MATERIALS AND METHODS

I. Experimental Model and Animal Subject Details
For all immunopanning and FACS experiments, C57BL/6J male and female mice
(Jackson Laboratory, Bar Harbor, ME; Jax 000664) were used with IACUC approval and
regulations, as seen in Appendix A.

II. Immunopanning
Petri dishes were coated with 30 µL of secondary antibody (dish 1: goat anti-rat IgG,
dish 2: goat anti-mouse IgG + IgM, dish 3: goat anti-mouse IgM, µ chain specific) in 10
mL of 50mM Tris-HCl. Plates were gently shifted from side to side to allow for the
bottom surface of each plate to be completely covered with solution and then incubated in
4ºC overnight. The next morning, the dishes were rinsed three times with D-PBS and a
solution of 0.2% BSA in D-PBS was added to each dish and left to incubate at room
temperature. After 30 minutes, the BSA solution was aspirated and each plate was coated
with their respective primary antibodies (dish 1: CD45, dish 2: Thy1.2, dish 3: O4). The
plates were left to incubate at room temperature for a minimum of 2 hours. While plates
were incubating, mice were euthanized by CO2 asphyxiation with secondary cervical
dislocation. Inguinal scWAT depots were dissected, weighed, and minced in a Petri dish
containing a collagenase/DMEM (high-glucose, serum-free) solution (concentration of
2mg/mL). The minced adipose depot was then transferred to a 50 mL conical tube with
10 mL collagenase/DMEM solution. DRG and sciatic were also dissected and
collectively pooled into two 15 mL tubes with 3.5 mL collagenase/DMEM solution. The
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covers of the conical tubes were loosely capped to prevent cell death. The samples were
placed in a shaking water bath at 37ºC and triturated every 15 minutes with glass pipettes
of various bores until adipocytes were floating and there were no chunks of tissue
remaining. Adipose solutions were then filtered into new tubes through 100 µm filters,
followed by a filter wash of 2 mL low-ovo working solution. Samples were then
centrifuged at 500g for 10 minutes to pellet the tissue. The collagenase/DMEM cocktail
was then aspirated out of each tube and replaced with 10 mL of low-ovo working
solution. Cells were then resuspended in 5 mL of panning buffer, filtered through 100 µm
cell strainers 1 mL at a time to remove any large pieces of debris, and the filters were
each washed with an additional 5 mL of panning buffer. Cells were left in 37ºC for 30-45
minutes to allow for cell recovery. Next, the primary antibodies were aspirated from the
Petri dishes and the dishes were each washed three times with D-PBS. Samples were
poured first onto their corresponding CD45 plates and incubated at room temperature for
20 minutes (lightly shaken at 10 minutes). Non-adherent cells were then transferred from
their CD45 plate to their Thy1.2 plate and incubated at room temperature for 20 minutes
(lightly shaken at 10 minutes). Cells that had adhered to the CD45 plate were lifted from
the plate using 200 µL of 2.5% trypsin in 4 mL of equilibrated EBSS and frozen in 50 µL
of Trizol Reagent, manually disrupted via trituration, and stored at -80ºC. Non-adherent
cells were then transferred from their Thy1.2 plate to their O4 plate and incubated at
room temperature for 20 minutes (lightly shaken at 10 minutes). Cells that had adhered to
the Thy1.2 plate were lifted from the plate using 200 µL of 2.5% trypsin in 4 mL of
equilibrated EBSS and frozen in 50 µL of Trizol Reagent, manually disrupted via
trituration, and stored at -80ºC. Non-adherent cells on the O4 plate were then frozen in 50
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µL of Trizol Reagent, manually disrupted via trituration, while cells that had adhered to
the O4 plate were lifted from the plate using 200 µL of 2.5% trypsin in 4 mL of
equilibrated EBSS and frozen in 50 µL of Trizol Reagent, manually disrupted via
trituration, and both populations were also stored at -80ºC.

CD4
5

Thy1.
2

O4

Figure 2. Schematic of the immunopanning procedure used for these experiments

III. Fluorescence-Activated Cell Sorting (FACS) Analysis
Mice were euthanized by CO2 asphyxiation with secondary cervical dislocation.
Inguinal scWAT depots were dissected, weighed, and minced in a Petri dish containing a
collagenase/DMEM (high-glucose, serum-free) solution (concentration of 2mg/mL). The
minced adipose depot was then transferred to a 50 mL conical tube with 10 mL
collagenase/DMEM solution. DRG and sciatic were also dissected and collectively
pooled into two 15 mL tubes with 3.5 mL collagenase/DMEM solution. The covers of the
conical tubes were loosely capped to prevent cell death. The samples were placed in a
shaking water bath at 37ºC and triturated every 15 minutes with glass pipettes of various
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bores until adipocytes were floating and there were no chunks of tissue remaining.
Samples were then filtered through 100 µm cell strainers into 50 mL tubes and rinsed
several times with DMEM. The samples were then centrifuged at 500g for 10 minutes to
separate the adipocytes and SVF. The SVF was collected by aspirating out the solution,
incubating the pellet in 500 µL of red blood cell (RBC) lysis buffer for 2 minutes on ice.
Following RBC lysis, 2 mL of DMEM (with serum) was added to stop the lysis and the
samples were centrifuged at 500g for 5 minutes at 4ºC. DMEM was decanted and cells
were resuspended in 100 µL FACS buffer (PBS with 5% FCS). Next, 4 µL of FACS
block per sample and sat on ice for 15-20 minutes. 500 µL of FACS buffer was added
and samples were spun at 1800 rpm for 5 minutes. Samples were then resuspended in 100
µL of FACS buffer with FACS antibodies (CD45-AF700, P75-VIOBRIGHT FITC, O4APC) for 20 minutes. Cells were then washed 2 times by centrifugation at 1500 rpm for 5
minutes and resuspended in 300 µL of ice cold FACS buffer. The cells were kept in the
dark and on ice for the transport to The Jackson Laboratory until the scheduled time of
analysis. During analysis, cell populations were sorted into Trizol Reagent in Eppendorf
tubes.
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IV. RNA Extraction

For RNA extraction, 2 small scoops of bullet blender beads was added to each
population of cells in their Safe-lock Eppendorf tubes, which were then paced into the
Bullet Blender on setting 6 for 3 minutes. Samples were centrifuged at 12,000g for 15
minutes in a refrigerated centrifuge. The supernatant was pipetted off (avoiding the tissue
debris and beads) into a new 1.5 mL nuclease-free tube. The tubes sit for 5 minutes at
room temperature. One volume of ice-cold 95-100% EtOH to each sample and mixed by
vortexing. Sample was immediately loaded into a labeled column tube and spun at
12,000g for 30 seconds. The flow-through was discarded into a waste beaker and the
remainder of the sample was re-run in the same manner until all RNA was bound to the
column. After the last spin, the column was transferred to a new collection tube and 400
µL of RNA Pre-Wash buffer was added to the column and spun at 12,000g for 30
seconds with flow through discarded. This step was then repeated. 700 µL of RNA Wash
Buffer was added to the column and then spun at 12,000g for 1 minute. Flow-through
was discarded and the empty column was spun at 12,000g for 2 minutes with the cap
open to dry the column. The column was transferred to a new 1.5 mL nuclease-free tube
and 50 µL of nuclease-free water was added directly to the middle of the column. This sat
for 1-5 minutes on ice to absorb the RNA from the column and spun at 12,000g for 1
minute to elute RNA. Samples stored at -80ºC.
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V. Qubit Analysis
For high sensitivity RNA measurement with Qubit analysis, Qubit Working Solution for
all tubes (standards, spike-in, and sample tubes) was prepared by diluting the RNA
Reagent (200x) into RNA HS Buffer, such that there were 180 µL per sample tube. 180
µL of Working Solution was pipetted out into two Standard tubes, followed by 10 µL of
nuclease-free water to each tube and 10 µL of Standard #1 and Standard #2, to their
respective tubes. Next, Master Mix was prepared by adding Standard #2 (10ng/µL) as our
spike-in RNA, and nuclease-free water to the tube containing the remaining Qubit
Working Solution. 199 µL of the Master Mix was aliquoted into each sample tube and
spike-in control, followed by 1 µL of each RNA sample to its respective sample tube, and
then 1 µL of nuclease-free water to each respective spike-in control tube. The solution
was vortexed for a few seconds and then spun down in the centrifuge for a few seconds.
Tubes were allowed to incubate at room temperature for two minutes in the dark to allow
the Qubit assay to reach optimal fluorescence. Standardization was first performed in the
Qubit by first inserting the Standard #1 tube, hitting measure, and then inserting the
Standard #2 tube and hitting measure. Next, the sample tubes were inserted and measured
in a recorded order. Values for final RNA levels were determined by putting the data onto
a flash drive and entering the numbers into an Excel file, where the RNA Spike-in control
values were able to be subtracted from the final read RNA values, therefore determining
the final RNA values in each sample.
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VI. Statistical Analysis
For statistical analysis, statistical calculations were conducted in either Excel or
GraphPad Prism software (La Jolla, CA, USA), using Student’s t-test and one-way and
two-way ANOVAs. All plots represent mean +/- SEM. For all figures, *p < 0.05, **p
<0.01, ***p < 0.001, ****p < 0.0001.
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RESULTS

I. Immunopanning Trial I for O4 Positive Cells in subcutaneous white adipose tissue
At 15 weeks old, four male C57BL/6JUM mice showed no significant difference in
RNA levels across the cell populations deemed CD45 positive, Thy1.2 positive, O4
positive, and O4 negative (Fig. 3). RNA levels in all populations were extremely low and
therefore had to be quantified using Qubit technology rather than Nanodrop. RNA levels
in the CD45+ population ranged from 0.66 ng/µL – 1.56 ng/µL. RNA levels in the
Thy1.2+ population ranged from 0.71 ng/µL – 0.97 ng/µL. RNA levels in the O4+
population were between 0.44 ng/µL – 1.05 ng/µL. RNA levels in the O4- population
were between 0.76 ng/µL – 1.24 ng/µL. While there was no statistical significance, it can
be seen from these numbers that the O4+ population had the smallest number for the low
end of the range.
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Figure 3. RNA quantification of different cell populations in Immunopanning Trial
1

II. Immunopanning Trial II for O4 Positive Cells in subcutaneous white adipose tissue
At the ages between 13 to 18 weeks, five male C57BL/6JUM mice showed a
significant difference in RNA levels between the CD45 positive Thy1.2 positive
populations (Fig. 4). RNA levels were again extremely low across the board, requiring
analysis by Qubit technology rather than Nanodrop. RNA levels in the CD45+ population
ranged from 0.65 ng/µL – 3.36 ng/µL. RNA levels in the Thy1.2+ population ranged
from -0.6 ng/µL (indicating extremely low levels or an error in extraction?) – 0.64 ng/µL.
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RNA levels in the O4+ population ranged from 0.06 ng/µL – 0.39 ng/µL. RNA levels in
the O4- population range from 2.51 ng/µL – 8.52 ng/µL.
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Figure 4. RNA quantification of different cell populations in Immunopanning
Trial 2
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III. Fluorescence-activated cell sorting (FACS) of different cell populations in
subcutaneous white adipose tissue
At the ages of 11 and 54 weeks, eight C57BL/6JUM mice were euthanized, and their
inguinal subcutaneous white adipose depot was digested to isolate the stromal vascular
fraction (SVF), which was then sorted into various cell populations which were isolated
through the cell-sorting mechanism known as FACS. When comparing the adipose tissue
of 11 week old mice to a 54 week old mice, there was a presence of p75+ cells with no
significant difference between the age groups, a sub-population of cells positive for both
CD45 and O4 with a statistically significant difference in the CD45+O4+ populations
between the two age groups, as well as CD45+p75+ and CD45+O4-High sub-populations
(Fig. 5, 6, 7). Although there were eight possible populations with the combinations of
the three markers used, only five populations were noted and gated (exclusion of
CD45+O4+p75+, CD45+O4-p75-, and CD45-O4+p75+ populations). There was a
statistical significance between mice 11 weeks of age and 54 weeks of age in the cell
populations labeled CD45+O4+p75- and CD45-O4-p75-. The relationship in the
CD45+O4+p75- population was a negative correlation with age, while the CD45-O4p75- population suggested a relationship that correlated positively with age (Fig. 8A).
Outliers were included in Figure 8B, but when removed for further comparative analysis,
there was still a significant statistical difference in the CD45+O4+p75- population.
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Figure 5. Weight differences between young and aged mice at tissue collection. (A)
Body weight of mice 11 weeks old compared to body weight of mice 54 weeks old at
time of tissue collection. (B) Subcutaneous white adipose tissue (scWAT) weight of mice
11 weeks old compared to scWAT of mice 54 weeks old at time of tissue collection.
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Figure 6. Density plots of the different cell populations represented in a young
animal. (A) Density plot showing gate for p75+ cell population. (B) Density plot
showing gate for CD45+O4+ cell population and CD45-O4-High cell population. (C)
Density plot showing lack of existence of an O4+p75+ cell population. (D) Density plot
showing gate for CD45+p75+ cell population.
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Figure 7. Density plots of the different cell populations represented in an old animal.
(A) Density plot showing gate for p75+ cell population. (B) Density plot showing gate
for CD45+O4+ cell population and CD45-O4-High cell population. (C) Density plot
showing lack of existence of an O4+p75+ cell population. (D) Density plot showing gate
for CD45+p75+ cell population.
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Figure 8. Density plots of the different cell populations represented in sciatic nerve.
(A) Density plot showing gate for p75+ cell population. (B) Density plot showing gate
for CD45+O4+ cell population and CD45-O4-High cell population. (C) Density plot
showing lack of existence of an O4+p75+ cell population. (D) Density plot showing gate
for CD45+p75+ cell population.

Cell populations expressing only O4, used commonly as a marker of mature
oligodendroyctes in the CNS and Schwann cells in the PNS, conveyed no statistically
significant difference between populations of mice aged 11 weeks and those aged 54
weeks (Fig. 9). Comparisons were done for both the total cell population and the percent
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cell count. Similarly, total cell populations and percent cell counts expressing
CD45+O4+p75- were measured and compared in mice ages 11 weeks and 54 weeks old
(Fig. 10). There was a statistically significant decrease in the aged cohort of mice
compared to the young cohort (Fig. 10B).
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Figure 9. Population in scWAT expressing only myelin marker O4 in young mice
compared to aged mice. (A) Total cell population of cells expressing CD45-O4+p75- in
mice 11 weeks and 54 weeks old. (B) Percent cell count of cells expressing CD45O4+p75- in mice 11 weeks and 54 weeks old.
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Figure 10. Population in scWAT expressing myelin marker O4 and common
leukocyte marker CD45 in young mice compared to aged mice. (A) Total cell
population of cells expressing CD45+O4+p75- in mice 11 weeks and 54 weeks old. (B)
Percent cell count of cells expressing CD45+O4+p75- in mice 11 weeks and 54 weeks
old.

As a categorical marker of Schwann cells throughout their developmental lineage,
p75 showed expression in two different populations (Fig. 11). Comparisons were done
for both the total cell population and the percent cell count of CD45+O4-p75+ (Fig. 11A,
11B). Similarly, total cell populations and percent cell counts expressing CD45-O4-p75+
were measured and compared in mice ages 11 weeks and 54 weeks old (Fig. 11C, 11D).
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Figure 11. Populations of cells in scWAT expressing p75. (A) Total cell population of
cells expressing CD45+O4-p75+ in mice 11 weeks and 54 weeks old. (B) Percent cell
count of cells expressing CD45+O4-p75+ in mice 11 weeks and 54 weeks old. (C) Total
cell population of cells expressing CD45-O4-p75+ in mice 11 weeks and 54 weeks old.
(D) Percent cell count of cells expressing CD45-O4-p75+ in mice 11 weeks and 54 weeks
old.
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The five cell populations were plotted relative to body weight. The two
populations that showed statistical significance were again, the CD45+O4+p75population and CD45-O4-p75- population; the former showing a negative correlation
with percentage of total cells to body weight and the latter showing a positive correlation
with percentage of total cells to body weight.
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Figure 12. Correlation between population cell percentage and body weight.
(A) The correlation between the CD45+O4-p75+ population cell percentage and body
weight. (B) The correlation between the CD45+O4+Pp5- population cell percentage and
body weight. (C) The correlation between the CD45-O4+p75- population cell percentage
and body weight. (D) The correlation between the CD45-O4-p75+ population cell
percentage and body weight, and (E) The correlation between the CD45-O4-p75population cell percentage and body weight.
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The five cell populations were also plotted relative to adipose weight. The only
population that showed statistical significance in these plots was the CD45+O4+p75population. This population showed a negative correlation between percentage of total cells
and adipose weight.
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Figure 13. Correlation between population cell percentage and adipose weight.
(A) The correlation between the CD45+O4-p75+ population cell percentage and adipose
weight. (B) The correlation between the CD45+O4+p75- population cell percentage and
adipose weight. (C) The correlation between the CD45-O4+p75- population cell
percentage and adipose weight. (D) The correlation between the CD45-O4-p75+
population cell percentage and adipose weight, and (E) The correlation between the CD45O4-p75- population cell percentage and adipose weight.
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DISCUSSION

While there is still an exorbitant amount of information that remains unanswered
about the mechanisms and roles of Schwann cells, there is even less information about
their roles in adipose tissue and therefore a lack of knowledge regarding implications of
the presence (or lack thereof) of Schwann cells in neuropathy in the subcutaneous
adipose depot. The phenotypic plasticity of Schwann cells constitutes their continuation
as an enigma in the peripheral nervous system, although researchers are slowly chipping
away at their various developmental stages, phenotypes, and associated roles and
molecular markers[33]. White adipose tissue is characteristically known for its role in
energy storage and for adipocytes being the major cellular constituent of the tissue. Only
recently has the importance of subcutaneous WAT and its innervation been recognized
for its role in peripheral neuropathy[17]. As this has been recent discussion, there hasn’t
been much focus – or any, really – on the existence of Schwann cells in adipose tissue
and their role in nerve health in these depots.

Immunopanning
Such low levels of RNA extracted from all cell populations in immunopanning
trials I and II are likely a result of there not being a large number of cells in each
population present in adipose tissue taken from a singular animal. While the left and right
depots were pooled, the depots from each individual animal were analyzed separately for
integrity. The extremity to which the RNA levels were low requires RNA amplification
before conversion to cDNA for analysis via quantitative polymerase chain reaction
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(qPCR) can occur. Finding an RNA amplification kit that works for the samples taken
and that is compatible with downstream Green SYBR chemistry for qPCR proved to be a
bit of a hassle. qPCR is a necessary technique that allows the samples to be analyzed for
gene expression of various genes. The major goal of this is two-fold; to ensure the cell
population isolated on each dish were congruent with what was anticipated, and to see
what characteristic markers of Schwann cells were expressed by the O4+ population, as
that population was anticipated to be solely Schwann cells. While there is a presence of
O4+ cells in both immunopanning trials I and II, it would be preemptive to claim solely
from this data that this population is Schwann cells. Also, it is important to note that
results from immunopanning trial II are more reliable for the reason that the collagenase
used in immunopanning trial I didn’t digest the tissue as well as we had hoped, so we
switched to collagenase A in the second trial and had much better luck with the digestion
of the adipose tissue.

FACS
The antibodies chosen for the FACS experiments were done so strategically. The
marker p75 is notorious for its role in marking both Schwann cell precursors (SCPs) and
non-myelinating Schwann cells, or Remak cells, as well as sometimes being used as a
marker of Schwann cells in general [52–54]. As seen in Figure 11, there was a presence
of a CD45+p75+ cell population as well as a solely p75+ cell population. Interestingly,
there was cell population that we gated indicating an overlapping presence of both of the
markers for O4 and p75. This is an intriguing note, as both have been used as markers for
mature Schwann cells in literature, yet there appears to be no overlapping population in
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the adipose tissues taken from the mice in this experiment. This could be indicative of a
niche population solely expressing p75 or one expressing both p75 and the common
leukocyte marker CD45. There was, however, a surprisingly low number of p75 cells.
This information combined with the lack of p75+/O4+ overlap, may suggest the need to
look at other antibody options, as some antibodies are tissue specific and therefore work
better in some tissues than others. When comparing the two age populations (mice at 11
weeks versus mice at 54 weeks), there was no statistically significant difference. This
indicates that age may not be an important factor in the number of SCPs or nonmyelinating Schwann cells present in the inguinal subcutaneous white adipose tissue.
Debatably, as age is historically a causative agent of peripheral neuropathy, these two
Schwann cell phenotypes may not be critical to preventing peripheral neuropathy and
maintaining nerve health in this manner.
There was also a sub-population of cells identified to be only O4+.
Oligodendrocyte marker 4 (O4) was chosen as a marker for myelinating Schwann cells.
Oligodendrocytes are the myelinating cell of the CNS and are quite similar to Schwann
cells in that regard. Therefore, O4 was previously used in the Cold Spring Harbor
protocol referenced for isolating and purifying Schwann cells, and is used throughout the
literature for marking myelinating Schwann cells[49,55]. The presence of O4+ cells does
further reiterate our findings from the immunopanning trials that there are myelinating
cells in these tissues. While these cells appear to have a negative trend with age, there is
no significant difference in total cell percentage between age groups. Comparatively to
the CD45+O4+ sub-population, this sub-population of exclusively O4+ cells constitutes a
miniscule percentage of the entire cell population.

42

The sub-population of cells sorted that commands the most attention is that of the
CD45+O4+. Cluster of differentiation 45 (CD45) is a known common leukocyte marker.
This is of interest, because leukocytes are responsible for the body’s immune response
through a widespread variety of mechanisms. Distinguishing cells with this marker is
critical, as the role of Schwann cells in immune responses is still being researched
intensely. Schwann cells are known for both their ability to recruit high levels of
leukocytes, such as macrophages and neutrophils, post-injury, as well as their ability to
change phenotypically to help in the axonal repair process[45,52,53]. During the sort, the
CD45+O4+ quickly became the most intriguing subset of cells. These cells both
expressed a marker well known for marking myelination, but also a very typical marker
of immune cells. These results indicate that there is a phenotypic population of cells
expressing proteins typically concurrent with myelination, that are also expressing the
same proteins as many leukocytes. This is a very interesting finding, as it reiterates the
potential role of Schwann cells (or Schwann-like cells) in immunity and repair.
Additionally, this population was the only population (aside from that reading negative to
all markers), that had a significant difference between age groups. Mice at the age of 11
weeks showed a significantly higher percentage of total cells that were CD45+O4+ when
compared to mice at the age of 54 weeks. As mentioned before, aging is a common
trigger for peripheral neuropathy, indicative of a correlation to declining nerve health.
There are also many neuropathies that develop as a result of demyelination [45]. The
significant decline in total cell percentage of cells that are CD45+O4+ is extremely
intriguing, as this is a group of cells previously unidentified to our knowledge. To further
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identify what these cells may be and their potential role in adipose and/or nerve health,
we must use qPCR to confirm gene expression.
Another intriguing difference to note is that in the sub-population of cells that
were negative for all markers, there was a statistical significance between age groups. In
this scenario, however, the opposite difference from the CD45+O4+ sub-population was
found, and the total percentage of cells that were negative for all markers increased
significantly with age. A hypothesis to consider is that as individuals age and cells
become senescent, they stop exhibiting the proteins responsible for immune responses
and myelination, and therefore fall into a category of no expression.
In Figures 12 and 13, the total cell percentages of each sub-population were
graphed relative to body weight (Fig. 12) and adipose weight (Fig. 13). Figure 12B shows
a statistically significant negative correlation between body weight (g) and total
percentage of CD45+O4+ cells. This finding carries over to Figure 13B, showing a
statistically significant negative correlation between adipose weight (g) and total
percentage of CD45+O4+ cells. Together, these results indicate that as body weight and
adipose weight increase, the number of CD45+O4+ cells decrease. This is relevant when
considering implications of the obesity epidemic. Literature shows that increased obesity
leads to many co-morbidities, including those previously listed in this thesis. If this subpopulation of cells (CD45+O4+) is critical for playing a role in maintaining nerve health,
this data would suggest that as individuals become more obese, they are more likely to
have a low percentage of these cells, and therefore are likely to have decreased
maintenance of nerve health in adipose tissue. Furthermore, obesity is defined by a larger
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fat mass, so the increased amount of fat would be pertinent to the fact that these cells
have been labeled in adipose tissue.
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FUTURE DIRECTIONS

Now that the immunopanning protocol has had most of its kinks worked out,
further experiments can be conducted using the developed protocol. Upon arrival of the
RNA amplification kit in the Townsend Lab, the RNA from both immunopanning trials
and FACS experiments can be amplified and converted into cDNA, at which point the
gene expression of the differing cell populations can be confirmed using primers we have
already designed for qPCR. Once the cell types in these populations are confirmed,
further conclusions can be drawn – from the immunopanning trials particularly.
Additionally, other antibodies can be used in the immunopanning protocol to
isolate different cell populations and speculate for previously unidentified ones. For
instance, there may be populations of cells exhibiting markers characteristic of other glia
or immune cell types that have yet to identified in adipose tissue. Emerging glial cells and
their respective roles are becoming apparent in areas such as the enteric nervous system,
so speculating the possibility of similar cell types residing in the adipose tissue and
playing an imperative role in nerve health is not unrealistic.
Furthermore, FACS can continue to be used as way to sort live cell populations.
Further studies should include valid young vs. aged cohort of females and one of males to
compare potential sex differences. Other interventions of interest that may show
important effects on adipose tissue are that of a high-fat diet and a cold versus room
temperature, respectively. As the FACS experiment in this thesis indicates a correlation
between adipose weight and sub-population of cells, it would be of interest to induce
obesity through a high-fat diet and compare sub-populations (such as that of CD45+O4+)
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in these mice relative to healthy mice. We have also seen that cold interventions exhibit
an increase in GAP43, a marker that indicates axonal cone outgrowth[17]. It would be
interesting to see how cell populations change over time based on cold exposure. If
axonal cone outgrowth increases in the cold and if cell sub-populations, such as
CD45+O4+, prove critical for nerve health or repair, it may be hypothesized that subpopulations such as this will also increase due to cold exposure.
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APPENDIX B

List of Designed Primers for qPCR

PTPRC
Forward: ATGGTCCTCTGAATAAAGCCCA
Reverse: TCAGCACTATTGGTAGGCTCC

Thy1.2
Forward: CTGCCATCACTGAAGAAGCC
Reverse: TTCTGCCACCCTCACTACAG

Cldn11
Forward: ATGGTAGCCACTTGCCTTCAG
Reverse: AGTTCGTCCATTTTTCGGCAG

EGR2/Krox20
Forward: GTGGATGTGTTGTGGTGGTC
Reverse: TGGGATTTTGTCTACGGCCT

S100b
Forward: GCCCTCATTGATGTCTTCCACC
Reverse: GAACTCATGGCAGGCCGTGGTC
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MPZ
Forward: GTCAAGTCCCCCAGTAGAA
Reverse: AGGAGCAAGAGGAAAGCAC

MBP
Forward: CAAGATGAAAACCCAGTAGTCCATT
Reverse: GAGGTGGTGTTCGAGGTGTCA

P75
Forward: GGTGATGGCAACCTCTACAGT
Reverse: CCTCGTGGGTAAAGGAGTCTA

GFAP
Forward: CGGAGACGCATCACCTCTG
Reverse: AGGGAGTGGAGGAGTCATTCG
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